子宫肌瘤对游离DNA筛查准确性的影响
结果显示肌瘤不影响常见常染色体三体或性染色体异常的筛查准确性,但肌瘤患者亚染色体异常假阳性率显著更高(2.0% vs 0.5%),且与肌瘤数量和体积正相关。
要点
- 肌瘤患者全基因组cfDNA筛查中亚染色体异常假阳性率约升高六倍
- 肌瘤数量和体积与亚染色体异常假阳性风险正相关
- 肌瘤不显著影响常见常染色体三体及性染色体异常的cfDNA筛查准确性
核心结论
- 大多数肌瘤患者全基因组cfDNA筛查结果正常,肌瘤主要导致亚染色体异常假阳性,但不影响常见常染色体三体和性染色体异常的筛查准确性。
研究设计与样本
- 所有病例在cfDNA筛查前接受超声检查确认孕周≥10周并记录肌瘤数量和体积,采用全基因组cfDNA筛查检测>7兆碱基的拷贝数变异。
诊断标准与关键数值
- 全基因组cfDNA筛查检测所有>7兆碱基的拷贝数变异。
- 肌瘤患者亚染色体异常假阳性风险约为无肌瘤者的六倍,且与肌瘤数量和体积正相关。
临床应用与阅片要点
- 对合并子宫肌瘤的孕妇解读全基因组cfDNA筛查结果时,应警惕亚染色体异常假阳性可能,结合超声肌瘤特征综合判断。
- 肌瘤数量和体积较大的患者,亚染色体异常假阳性风险更高,报告时需提示临床注意。
局限性
- 研究仅纳入两个中心,外推性需进一步验证。
- 未报告肌瘤位置(如黏膜下、肌壁间)对cfDNA筛查准确性的影响。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: Cell-free DNA (cfDNA) screening assesses both maternal and placental cfDNA. Fibroids are common and release cfDNA into maternal serum. Genetic abnormality is seen in 50% of fibroids. We aimed to assess the impact of fibroids on the accuracy of genome-wide cfDNA screening.
METHODS: This was a prospective cohort study of singleton pregnancies examined at one of two centers in Melbourne and Sydney, Australia, between 1 November 2019 and 31 December 2020. All cases underwent pretest ultrasound examination to confirm an ongoing pregnancy of at least 10 weeks' gestation, and, at this stage, the number and volume of any uterine fibroid were documented. Genome-wide cfDNA screening was performed to detect all copy-number variants (CNV) > 7 megabases. The incidence of a false-positive result was compared between cases with and those without fibroids.
RESULTS: Over the 14-month study period, 13 184 patients underwent cfDNA screening, of whom 1017 (7.7%) had fibroids. Fibroids were not identified in any of the 17 participants who had a false-positive result for chromosomes 13, 18, 21, X or Y. Ninety-five (0.7%) cases were screen-positive for subchromosomal aberration (SA), rare autosomal trisomy (RAT) or multiple abnormalities (MA), with 10 of these cases having a fetal genetic abnormality. The incidence of a false-positive RAT, MA or SA result was significantly higher in participants with fibroids (20/1017 (2.0%)) than in those without fibroids (64/12 167 (0.5%)). Women with fibroids were approximately six times as likely to have a false-positive result for SA, and this was associated positively with both fibroid number and volume.
CONCLUSIONS: Most women with fibroids do not have an abnormal result on genome-wide cfDNA screening. However, CNVs due to fibroids are associated with false-positive SA findings, although fibroids do not appear to influence cfDNA screening accuracy for the common autosomal trisomies or sex-chromosomal abnormalities. © 2021 International Society of Ultrasound in Obstetrics and Gynecology.
引用
- Scott F, Menezes M, Smet ME, et al. Influence of fibroids on cell-free DNA screening accuracy. Ultrasound Obstet Gynecol. 2022. PMID: 34396623. doi:10.1002/uog.23763
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。